|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
FDA Wins Fight Against Regenerative Sciences
8/1/2012 7:12:27 AM
For the past four years, the FDA has been locked in a dispute with a little-known company called Regenerative Sciences that claimed it was a medical practice using stem cells to perform non-surgical procedures. The FDA, however, argues the procedure actually amounted to the use of drugs that were never approved under a biologics license application or new drug application. In other words, what Regenerative was doing was unlawful and the agency sought an injunction. After enduring FDA inspections, Regenerative fired back by filing a lawsuit against the FDA, claiming the agency lacked jurisdiction (back story). Now, though, Regenerative has lost its case. While calling it a close call, a federal judge last week ruled in favor of the FDA and agreed the agency has the right to regulate therapies made from a patient’s own processed stem cells, setting the stage for oversight of a largely unregulated field.
|
|
|
|
|
|
|
|
|
|
|